Whole-exome sequencing confirms implication of VPS13D as a potential cause of progressive spastic ataxia

Archive ouverte

Durand, Christelle | Angelini, Chloé | Michaud, Vincent | Delleci, Claire | Coupry, Isabelle | Goizet, Cyril | Trimouille, Aurelien

Edité par CCSD ; BioMed Central -

International audience. Background: VPS13D is a large ubiquitin-binding protein playing an essential role in mitophagy by regulating mitochondrial fission. Recently, VPS13D biallelic pathogenic variants have been reported in patients displaying variable neurological phenotypes, with an autosomic recessive inheritance. The objectives of the study were to determine the genetic etiology of a patient with early onset sporadic progressive spastic ataxia, and to investigate the pathogenicity of VPS13D variants through functional studies on patient's skin fibroblasts. Case presentation: We report the case of a 51-year-old patient with spastic ataxia, with an acute onset of the disease at age 7. Walking difficulties slowly worsened over time, with the use of a wheelchair since age 26. We have used trio-based whole-exome sequencing (WES) to identify genes associated with spastic ataxia. The impact of the identified variants on mitochondrial function was assessed in patient's fibroblasts by imaging mitochondrial network and measuring level of individual OXPHOS complex subunits. Compound heterozygous variants were identified in VPS13D: c.946C > T, p.Arg316* and c.12416C > T, p.(Ala4139Val). Primary fibroblasts obtained from this patient revealed an altered mitochondrial morphology, and a decrease in levels of proteins from complex I, III and IV. Conclusions: Our findings confirmed implication of VPS13D in spastic ataxia and provided further support for mitochondrial defects in patient's skin fibroblasts with VPS13D variants. This report of long-term follow up showed a slowly progressive course of the spastic paraplegia with cerebellar features. Furthermore, the performed functional studies could be used as biomarker helping diagnosis of VPS13D-related neurological disorders when molecular results are uneasy to interpret.

Suggestions

Du même auteur

Prevalence of Fabry disease in patients with chronic pain: Lessons from the DOUFAB and DOUFABIS studies

Archive ouverte | Angelini, Chloé | CCSD

International audience. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC ®.Background: Fabry disease (FD) is a rare X-linked lysosomal disorder caused by a...

Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes

Archive ouverte | Angelini, Chloé | CCSD

International audience. Abstract Background Mitochondrial membrane protein‐associated neurodegeneration (MPAN) is caused by mutations in the C19orf12 gene. MPAN typically appears in the first two decades of life and...

Rare variants in the GABAA receptor subunit epsilon identified in patients with a wide spectrum of epileptic phenotypes

Archive ouverte | Markus, Fenja | CCSD

BACKGROUND: Epilepsy belongs to a group of chronic and highly heterogeneous brain disorders. Many types of epilepsy and epileptic syndromes are caused by genetic factors. The neural amino acid y-aminobutyric acid (GABA) is a major...

Chargement des enrichissements...